Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of RNA interference therapeutics for genetically ...

The shift to personalized medicine, where companies can develop preventive measures and precision treatments to enhance a patient’s unique well-being, ...

Cell therapy, as defined by the American Society of Gene & Cell Therapy, is “the administration of living whole cells ...

The global life sciences industry is on the verge of a revolution that will change how products are developed, marketed, ...

Value-based care models are the future of pharmaceuticals but several obstacles exist slowing the transition from volume selling to value selling. ...

With industry-leading experience designing, configuring, validating, and/or deploying LIMS software solutions for our clients, we’ve had the amazing opportunity to impact ...

The Story of the Largest LIMS Implementation in History Clarkston Consulting embarked on a first-of-its-kind project implementing LIMS with one ...

Genomic medicine has long offered the promise of gene-based disease prevention and treatment—allowing medical providers to successfully predict, prevent, and ...

Is the market starting to reward innovator pharmaceutical companies that are promising value-based care contracts? To an industry outsider, pharmaceutical ...

Since quality management’s inception at the turn of the 20th century, life sciences business leaders have predominantly viewed the field ...

In 2008, the European Medicines Agency began discussing serialisation requirements for pharmaceutical manufacturers—if you’re unfamiliar with serialisation this video is ...

Just like the design-thinking revolution in software, we are in the midst of a patient-centered care revolution in healthcare. For ...